14-52864622-C-T
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 1P and 4B. PP3BS2
The NM_006832.3(FERMT2):c.1381G>A(p.Glu461Lys) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000547 in 1,461,554 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 14/24 in silico tools predict a damaging outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006832.3 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FERMT2 | NM_006832.3 | c.1381G>A | p.Glu461Lys | missense_variant, splice_region_variant | Exon 12 of 15 | ENST00000341590.8 | NP_006823.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000279 AC: 7AN: 251232 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461554Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 727100 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1381G>A (p.E461K) alteration is located in exon 12 (coding exon 11) of the FERMT2 gene. This alteration results from a G to A substitution at nucleotide position 1381, causing the glutamic acid (E) at amino acid position 461 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at